Bayer CropScience Ltd Financials

Bayer CropScience Ltd Financial Statement

Bayer CropScience Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024	Mar 2024
Revenue	1,761.30	1,658.70	821.10
Operating Expense	1,553.80	1,317.20	694.90
Net Profit	136.30	254.20	96
Net Profit Margin	7.74	15.33	11.69
Earning Per Share	30.33	56.56	21.36
EBIDTA	207.70	340.30	128.10
Effective Tax Rate	26.02	17.69	8.95

Particulars	Sep 2024
Revenue	1761.30
Operating Expense	1553.80
Net Profit	136.30
Net Profit Margin	7.74
Earning Per Share	30.33
EBIDTA	207.70
Effective Tax Rate	26.02

Bayer CropScience Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	5,103.20	5,139.70	4,734.40
Operating Expenses Annual	4,149.20	4,215.50	3,923.30
Operating Profit Annual	1,035	1,091.90	924.20
Interest Annual	19.60	22.30	12.90
Depreciation	37.60	38.50	39.60
Net Profit Annual	740.50	758.20	645.30
Tax Annual	200.90	231.90	201.50

Particulars	Mar 2024
Total Revenue Annual	5,103.20
Operating Expenses Annual	4,149.20
Operating Profit Annual	1,035
Interest Annual	19.60
Depreciation	37.60
Net Profit Annual	740.50
Tax Annual	200.90

Bayer CropScience Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	860.80	780.90	1,204.50
Cash Flow from Operations	951.60	609.30	215.50
Cash Flow from Investing	0.40	83.30	64.20
Cash Flow from Financing	-656.30	-613.20	-703.30
Cash Flow at the End	1,156.50	860.30	780.90

Particulars	Mar 2024
Cash Flow at the Beginning	860.80
Cash Flow from Operations	951.60
Cash Flow from Investing	0.40
Cash Flow from Financing	-656.30
Cash Flow at the End	1,156.50

Bayer CropScience Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	20.28	19.22	19.52
PBIT Margin (%)	18.83	17.67	18.16
PBT Margin (%)	17.87	16.88	16.75
Net PROFIT Margin (%)	14.51	14.75	13.63
Return On Networth / Equity (%)	26.63	25.91	25.43
Return On Networth /Employed (%)	32.25	32.05	31.79
Return On Assets (%)	24.81	26.70	23.85
Total Debt / Equity (X)	0.02	0.03	0.02
Asset Turnover Ratio (%)	1.71	1.81	1.75

Particulars	Mar 2024
PBDIT Margin (%)	20.28
PBIT Margin (%)	18.83
PBT Margin (%)	17.87
Net PROFIT Margin (%)	14.51
Return On Networth / Equity (%)	26.63
Return On Networth /Employed (%)	32.25
Return On Assets (%)	24.81
Total Debt / Equity (X)	0.02
Asset Turnover Ratio (%)	1.71

Bayer CropScience Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	501.60	543.10	526.40
Total Current Assets Annual	3,905.50	3,896.40	3,575.50
Non Current Assets Annual	691.60	782.20	777.40
Total Shareholders Funds Annual	2,849.40	2,712.10	2,524.30
Total Assets Annual	4,597.10	4,678.60	4,352.90

Particulars	Mar 2024
Fixed Assets Annual	501.60
Total Current Assets Annual	3,905.50
Non Current Assets Annual	691.60
Total Shareholders Funds Annual	2,849.40
Total Assets Annual	4,597.10

Bayer CropScience Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 25, 2024, Bayer CropScience Ltd has a market capitalization of 23,563.36 Cr. Value Research classifies it as a Large-Cap company.

Yes, Bayer CropScience Ltd is debt-free with a debt-to-equity ratio of 0.02.

In FY 2023 , Bayer CropScience Ltd recorded a total revenue of approximately 5,103.20 Cr marking a significant milestone in the company's financial performance.

Bayer CropScience Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.0% and 0.0% annually, respectively..

Bayer CropScience Ltd's current PE ratio is 31.82.

Bayer CropScience Ltd's ROCE averaged 32.9% from the FY ending March 2022 to 2024, with a median of 32.9%. It peaked at 33.2% in March 2024, reflecting strong capital efficiency over the period..

Bayer CropScience Ltd's latest EBIT is Rs. 961 Cr, surpassing the average EBIT of Rs. 944.37 Cr over the 5 years..